rs765926471
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_001010867.4(IBA57):c.286T>C(p.Tyr96His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000289 in 1,385,786 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000029 ( 0 hom. )
Consequence
IBA57
NM_001010867.4 missense
NM_001010867.4 missense
Scores
10
5
4
Clinical Significance
Conservation
PhyloP100: 2.87
Genes affected
IBA57 (HGNC:27302): (iron-sulfur cluster assembly factor IBA57) The protein encoded by this gene localizes to the mitochondrion and is part of the iron-sulfur cluster assembly pathway. The encoded protein functions late in the biosynthesis of mitochondrial 4Fe-4S proteins. Defects in this gene have been associated with autosomal recessive spastic paraplegia-74 and with multiple mitochondrial dysfunctions syndrome-3. Two transcript variants encoding different isoforms have been found for this gene. The smaller isoform is not likely to be localized to the mitochondrion since it lacks the amino-terminal transit peptide. [provided by RefSeq, Jul 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.972
PP5
Variant 1-228166102-T-C is Pathogenic according to our data. Variant chr1-228166102-T-C is described in ClinVar as [Pathogenic]. Clinvar id is 545649.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IBA57 | NM_001010867.4 | c.286T>C | p.Tyr96His | missense_variant | 1/3 | ENST00000366711.4 | NP_001010867.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IBA57 | ENST00000366711.4 | c.286T>C | p.Tyr96His | missense_variant | 1/3 | 2 | NM_001010867.4 | ENSP00000355672 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome AF: 0.00000289 AC: 4AN: 1385786Hom.: 0 Cov.: 33 AF XY: 0.00000146 AC XY: 1AN XY: 684042
GnomAD4 exome
AF:
AC:
4
AN:
1385786
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
684042
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Multiple mitochondrial dysfunctions syndrome 3 Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | The Molecular Genetic and Pathologic Diagnosis Center of Neuromuscular Disorder, Children's Hospital of Fudan University | Dec 01, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Molecular Diagnostic Laboratory, Beijing Chigene Translational Medicine Research Center | - | Through Trio-WES, compound heterozygous variants in the IBA57 gene were identified in the proband's testing data, which are [c.286T>C/p.Y96H] and [c.754G>A/p.G252S]. The c.286T>C variant is predicted to result in the substitution of the 96th amino acid in the protein from Tyrosine (Tyr) to Histidine (His), inherited from the father. The c.754G>A variant is predicted to result in the substitution of the 252nd amino acid in the protein from Glycine (Gly) to Serine (Ser), inherited from the mother. The c.286T>C variant has the rs number rs765926471 and is not recorded in general population carrier frequency databases such as the Thousand Genomes Project or gnomAD. According to the ACMG guidelines, this variant is classified as a pathogenic variant: PM2_Supporting + PM3_VeryStrong + PP1_Moderate + PP3, with the specific basis as follows: PM3_VeryStrong:The variant has been detected as a homozygous variant or in trans phase with pathogenic (P) or likely pathogenic (LP) variants, or in trans phase with variants of uncertain significance (VUS) in one or more patients with a phenotype correlation, achieving a PM3-Case_Score of ≥4.0 [PMID: 28671726, 32348839]. PP1_Moderate:The variant has been found to co-segregate at least twice in the self-check case database and literature reports for recessive diseases or at least four times for dominant diseases [PMID: 28671726]. PP3:Various bioinformatics computational methods predict that the variant has a deleterious effect on the gene/gene product or affects splicing to a level that meets the supportive threshold. In summary, this variant meets criteria to be classified as pathogenic based on the ACMG/AMP criteria applied. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 25, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
H
MutationTaster
Benign
D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D
REVEL
Pathogenic
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MutPred
Gain of disorder (P = 0.0268);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at